Seeking Alpha

India's Supreme Court has postponed until Sept. 11 a crucial hearing over whether to grant...

India's Supreme Court has postponed until Sept. 11 a crucial hearing over whether to grant patent protection to Novartis' (NVS) leading cancer drug Glivec, which the Indian government declined to provide. The hearing was due to take place today. The decision could affect how Big Pharma operates in India, and curb the country's leading position as a supplier of cut-price generic medicines. (previous)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs